Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
DRUG ELUTING BALLOONS (DCB/DEB)
A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas - Kidney International
Current Results of Drug Coated Balloons - ppt download
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis | Journal of the American College of Cardiology
DRUG ELUTING BALLOONS (DCB/DEB)
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group | JACC: Cardiovascular Interventions
DRUG ELUTING BALLOONS (DCB/DEB)
Current Results of Drug Coated Balloons for Infrapopliteal Disease - ppt download
Drug-Coated Balloons: - ppt download
Drug-Eluting Balloon Catheters Market Size, Report 2022-2030
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Next generation stent coatings: convergence of biotechnology and nanotechnology: Trends in Biotechnology
Drug-coated balloon therapy in coronary and peripheral artery disease | Nature Reviews Cardiology
Drug eluting stent
PPT - Drug-eluting stents for in-stent restenosis PowerPoint Presentation - ID:9680829
Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study | PLOS ONE
PPT – Drug Eluting VS Bare Metal Stents PowerPoint presentation | free to view - id: 22de4c-ZDc1Z
DRUG ELUTING BALLOONS (DCB/DEB)
Are Drug Coated Balloons a Game Changer? - ppt download
PPT - Drug-eluting stents, bare-metal stents, or balloon-only angioplasty for below-the-knee disease PowerPoint Presentation - ID:1474444
PPT - Current Status of DRUG ELUTING BALLOONS FOR SFA/POP INTERVENTION PowerPoint Presentation - ID:2193837
The Evolution of Drug-Eluting Stents | tctmd.com
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine
Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih, - ppt download
